SmartPill gets FDA nod

The SmartPill has received FDA approval, arriving in its second iteration. This device is meant to be used to evaluate one’s constipation, measuring temperature and pH levels as it moves through the GI tract, while offering temporal-spacial analysis of its voyage. It has already been approved for analysis of suspected delayed gastric emptying (gastroparesis). Inside the SmartPill lies a GI Monitoring System that is capable of transmitting data wirelessly to the SmartPill Data Receiver. The latter is then returned to the physician’s office, where collected information will be downloaded onto a computer to be interpreted correctly.